Literature DB >> 11333549

[Validity of an indicator of the quality of pharmacological prescription in patients with hyperlipemia].

M Fernández San Martín1, C López Bilbao, E Escortell Mayor, T Sanz Cuesta, L Fidalgo García, C Rodríguez Escolar.   

Abstract

OBJECTIVES: The computer system for billing prescriptions (SIFAR in Spanish) enables indicators to be extracted for the study and follow-up of the use of medicines in the INSALUD primary care areas. Concretely, we studied the indicator referring to pensioners consumption of lipid-lowering drugs (PCLL), not validated, and whose value is expected to drop as quality increases. The objective was to calculate the correlation of the indicator of prescription of lipid-lowering drugs on the SIFAR with the proportion of lipid-lowerers prescribed correctly for pensioners (PCP).
DESIGN: A descriptive study of correlation between two indicators of drug prescription.
SETTING: Four health districts in Madrid. PARTICIPANTS: The prescriptions of 49 general practitioners, chosen at random on the basis of three strata defined by the value of the indicator, were studied. Each doctor filled out a protocol of data for each pensioner patient to whom he/she prescribed a lipid-lowerer during the study period.
MEASUREMENTS AND MAIN RESULTS: The PCLL and PCP indicators were compared through the correlation of Spearman. 6,779 prescriptions for 1,125 patients were collected from the 49 participating doctors. The mean percentage of lipid-lowerers correctly prescribed was 31.9%, figure that rose to 77.5% when the LDL value was not specified. The correlation between the PCLL and the PCP was near zero.
CONCLUSIONS: The PCLL indicator of the SIFAR does not discriminate quality in lipid-lowering drug prescription to people over 64.

Entities:  

Mesh:

Year:  2001        PMID: 11333549      PMCID: PMC7681371          DOI: 10.1016/s0212-6567(01)79372-9

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  7 in total

1.  [Set of indicators for the assessment of the degree to which drug therapy guide is followed in primary care].

Authors:  A I Rigueira García; V Gómez Juanes
Journal:  Rev Esp Salud Publica       Date:  2000 Jan-Feb

2.  [Analysis of prescriptions in primary care: evaluation of a system of indicators].

Authors:  E Amado; R Madridejos; M T Pérez; A Catalán
Journal:  Aten Primaria       Date:  1997-10-31       Impact factor: 1.137

3.  [The validity of therapeutic utility and intrinsic value as indicators of drug prescription quality: an analysis of treatments in cases of the common cold].

Authors:  P J Saturno Hernández; J J Gascón Cánovas
Journal:  Aten Primaria       Date:  1997-05-15       Impact factor: 1.137

4.  Criteria for use of hypolipidemic agents in adults.

Authors:  E Morales; S A Spinler; M D Wilson; M M Chin; E Jozefiak
Journal:  Am J Hosp Pharm       Date:  1994-11-15

5.  Cholesterol in the elderly. Is it important?

Authors:  S B Hulley; T B Newman
Journal:  JAMA       Date:  1994-11-02       Impact factor: 56.272

6.  [The quality of the drug treatment in hyperlipemia patients from 4 health areas. The VICAF Group].

Authors:  T Sanz Cuesta; E Escortell Mayor; M I Fernández San Martín; C López Bilbao; B Medina Bustillo; C Torres Bouza
Journal:  Aten Primaria       Date:  2000-10-15       Impact factor: 1.137

7.  Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years.

Authors:  H M Krumholz; T E Seeman; S S Merrill; C F Mendes de Leon; V Vaccarino; D I Silverman; R Tsukahara; A M Ostfeld; L F Berkman
Journal:  JAMA       Date:  1994-11-02       Impact factor: 56.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.